TARSIER PHARMA
Tarsier Pharma is a late clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune and inflammatory ocular diseases. The TRS Platform Technology is a bio-inspired immunomodulator designed to treat blinding inflammatory ocular diseases and is currently being developed as both eye drops and intravitreal injections. Ocular inflammations are a group of diseases affecting the front and back of the eye... . Non-infectious anterior and posterior uveitis is the most known ocular inflammatory disease. However, ocular inflammation is a critical underlying mechanism in the pathology of other inflammatory eye diseases, such as non-evaporative dry eye, diabetic macular edema (DME), and dry age-related macular degeneration (AMD). Hundreds of millions of people in all age groups are suffering from ocular inflammatory diseases worldwide, conditions that pose severe risks of vision loss and blindness.
TARSIER PHARMA
Industry:
Biopharma Medical Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Haifa, Hefa, Israel
Country:
Israel
Website Url:
http://www.tarsiuspharma.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.4 M USD
Technology used in webpage:
SPF Amazon Microsoft Exchange Online Office 365 Mail Google Apps For Business GoDaddy DNS AWS Global Accelerator
Similar Organizations
Artax Biopharma
Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Bichen Pharmaceutical
Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.
dMed
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
Horizon 2020
Horizon 2020 investment in Grant - Tarsier Pharma
Sun Pharmaceutical Industries
Sun Pharmaceutical Industries investment in Corporate Round - Tarsier Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2024-05-28 | Tarsier Pharma Announces the Appointment of Emilee Fulcher as Vice President of Clinical Affairs |
Official Site Inspections
http://www.tarsiuspharma.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Tarsier Pharma"
Tarsier Pharma - Crunchbase Company Profile & Funding
Tarsier Pharma is a late clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of …See details»
Tarsius Pharma Company Profile | Management and Employees …
Tarsius Pharma was established in 2016 and is focused on developing TRS, a breakthrough, bio-inspired platform technology for the treatment of blinding ocular diseases. The company's …See details»
Tarsier Pharma Overview | SignalHire Company Profile
Mar 1, 2022 Tarsier Pharma is a late clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of …See details»
Tarsius Pharma - Company Profile & Staff Directory - ContactOut
Discover Tarsius Pharma company details, including staff directory, contact information, and industry insights. Explore alternatives, competitors, and frequently asked questions to get …See details»
Tarsier Pharma - VentureRadar
Tarsius Pharma is a clinical stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune and …See details»
Tarsius Pharma - Overview, News & Competitors | ZoomInfo.com
Tarsius Pharma was established in 2016 and is focused on developing TRS, a breakthrough, bio-inspired platform technology for the treatment of blinding ocular diseases. The company's …See details»
Tarsier Pharma - Contacts, Employees, Board Members
Tarsier Pharma is a late clinical-stage company that develops treatment for autoimmune and inflammatory ocular diseases.See details»
Tarsius Pharma Ltd. Company Profile Information|Tarsius Pharma …
Tarsius Pharma Ltd. Company Profile Information is operating as a Private Company - Operating. It was officially incorporated on 01 January, 1970, making the company 7 years old. The …See details»
Tarsius Pharma - CoBee Company Profile & Funding Rounds
Tarsius Pharma is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of inflammatory ocular diseases. Contact Phone: +15163403599See details»
Tarsier Pharma Company Profile 2024: Valuation, …
Tarsier Pharma General Information Description. Develper of bio-inspired therapies intended to treat ocular inflammatory diseases. The company engages in the development and commercialization of a therapeutic approach for …See details»
Investor Relations - Tarsier® Pharma
Nov 13, 2023 Investor Relations Investor Relations CORPORATE PROFILE We are a clinical late-stage pharmaceutical company focused on the development and commercialization of …See details»
Tarsius Pharma DMF, CEP, Written Confirmations, FDF, Prices, …
Tarsius Pharma is a clinical stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune and …See details»
Tarsius Pharma - Products, Competitors, Financials, Employees ...
Tarsier Pharma's Positive End-of-Phase 2 Meeting with the U.S. FDA Sets Stage for TRS01 Phase III Program in Uveitis. Dec 17, 2020 | Source: Tarsius Pharma TEL-AVIV, Israel, Dec. …See details»
Tarsier Pharma - Funding, Financials, Valuation & Investors
Tarsier Pharma is a late clinical-stage company that develops treatment for autoimmune and inflammatory ocular diseases.See details»
Tarsius Pharma - Company Profile - Tracxn
Oct 11, 2024 Tarsius Pharma ranks 77th among 166 active competitors. 55 of its competitors are funded while 49 have exited. Overall, Tarsius Pharma and its competitors have raised over …See details»
Tarsier Pharma Company Profile: Overview and Full News Analysis
Tarsiuspharma.com. Overview: Tarsier Pharma. Tarsier Pharma is a pharmaceutical company based in Hefa, known for its innovative products and services in the healthcare industry. The …See details»
Tarsier Pharma DMF, CEP, Written Confirmations, FDF
Tarsier Pharma// Tarsier™ Pharma (doing business as Tarsius Pharma Ltd.) is a late clinical-stage company dedicated to the development and commercialization of a breakthrough …See details»
Tarsius Pharma Achieves Positive Results in Proof of Concept …
Oct 5, 2020 About Tarsius Pharma. Tarsius Pharma was established in 2016 and is focused on developing TRS, a breakthrough, bio-inspired platform technology for the treatment of blinding …See details»